At a glance
The Pancreatic Cancer Research Program Idea Development Award funds innovative, high-risk research aimed at improving outcomes for people with pancreatic cancer, and applications must address at least one FY26 PCARP focus area. Applicants can be U.S. Department of War organizations, including foreign or domestic, for-profit or nonprofit, and public or private entities, and investigators may be of any nationality or citizenship if affiliated with an eligible organization. The program expects about $9.9 million to fund about 12 awards, with total costs capped at $700,000 for a single PI or $950,000 for the Partnering PI option, for up to 3 years. Cost sharing is not required, and the announcement says it allows clinical research studies but not clinical trials; it also says painful research involving domestic cats or dogs is not supported except for studies relating to military or service animals.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism supports innovative ideas with the potential to yield impactful data and new avenues of investigation. All applications must address at least one of the FY26 PCARP Focus Areas . Distinctive Features: This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Partnering Principal Investigator (PI) Option for Early-Career Investigator: This funding mechanism offers a higher level of funding for applications that propose to partner an experienced PI (i.e., Initiating PI, who will serve as the mentor) with an Early-Career Investigator (i.e., Partnering PI) wishing to pursue a career in pancreatic cancer research. For this option, only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Who can apply
- Unrestricted